About Limelight bio

About company

Limelight Bio is a multi-platform, multi-disease focused biopharmaceutical company expanding the limits of gene therapy. The company is developing novel gene therapies that greatly expand the utility of clinically-validated AAV vectors to enable the treatment of debilitating inherited diseases that cannot be addressed by current technologies; such as those caused by mutations in large genes and autosomal dominant inheritance patterns. Limelight Bio's proprietary technologies are designed to overcome limitations of currently available viral-based treatments to address a wider range of diseases. It was founded in 2016 and is headquartered in Philadelphia, Pennsylvania, United States.